» Articles » PMID: 35156900

CircMMD_007 Promotes Oncogenic Effects in the Progression of Lung Adenocarcinoma Through MicroRNA-197-3p/protein Tyrosine Phosphatase Non-receptor Type 9 Axis

Overview
Journal Bioengineered
Date 2022 Feb 14
PMID 35156900
Authors
Affiliations
Soon will be listed here.
Abstract

Circular RNAs play important roles in cancer biology. In this research, we explored the underlying function and mechanism of cirMMD_007 in lung adenocarcinoma (LC). Clinical lung adenocarcinoma samples were obtained from surgery. Bioinformatic databases were used to predict miRNAs that can potentially target circRNAs and miRNA target genes. hsa_circMMD_007, miR-197-3p, and PTPN9 mRNA expressions were investigated by qRT-PCR. Protein expressions were examined using Western blot. The proliferation abilities were assessed by Cell Counting Kit-8 assays. Wound healing cell migration assay was applied to evaluate cell migration ability. Luciferase reporter assay and rescue experiments were then performed to elucidate the underlying mechanism. We found that the expression of circMMD_007 was abnormally increased in LC. The expression of circMMD_007 was higher in advanced stages. Knockout of circMMD_007 hindered the tumorigenesis of LC in vivo and in vitro. circMMD_007 could negatively regulate the expression of miR-197-3p. PTPN9 behaved to be a molecular target of miR-197-3p. In summary, this research demonstrated that circular RNA circMMD_007 could promote the oncogenic effects in the progression of LC through miR-197-3p/PTPN9 axis.

Citing Articles

Evaluation of hsa_circ_0000018/let-7f-5p/ FAM96A axis in lung adenocarcinoma progression.

Li Q, Zhao M, Hu D, Qin J, He W Cancer Biomark. 2023; 39(3):187-195.

PMID: 38043005 PMC: 11191447. DOI: 10.3233/CBM-230111.


MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy.

Song Y, Kelava L, Kiss I Int J Mol Sci. 2023; 24(17).

PMID: 37686110 PMC: 10487838. DOI: 10.3390/ijms241713302.


circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling.

Xu S, Luo C, Chen D, Tang L, Cheng Q, Chen L J Exp Clin Cancer Res. 2023; 42(1):64.

PMID: 36932454 PMC: 10021944. DOI: 10.1186/s13046-023-02642-z.


Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review).

Wang F, Yu C, Chen L, Xu S Int J Oncol. 2022; 62(2).

PMID: 36562354 PMC: 9812256. DOI: 10.3892/ijo.2022.5469.


Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy.

Tang X, Qi C, Zhou H, Liu Y Front Oncol. 2022; 12:972906.

PMID: 35957898 PMC: 9360549. DOI: 10.3389/fonc.2022.972906.


References
1.
Shukla S, Evans J, Malik R, Feng F, Dhanasekaran S, Cao X . Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma. J Natl Cancer Inst. 2016; 109(1). PMC: 5051943. DOI: 10.1093/jnci/djw200. View

2.
Zhao J, Li L, Wang Q, Han H, Zhan Q, Xu M . CircRNA Expression Profile in Early-Stage Lung Adenocarcinoma Patients. Cell Physiol Biochem. 2017; 44(6):2138-2146. DOI: 10.1159/000485953. View

3.
Chalela R, Curull V, Enriquez C, Pijuan L, Bellosillo B, Gea J . Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy. J Thorac Dis. 2017; 9(7):2142-2158. PMC: 5542927. DOI: 10.21037/jtd.2017.06.20. View

4.
Yang T, Li H, Chen T, Ren H, Shi P, Chen M . LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis. Mol Cells. 2019; 42(3):270-283. PMC: 6449715. DOI: 10.14348/molcells.2019.2364. View

5.
Chen Y, Wang X . miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2019; 48(D1):D127-D131. PMC: 6943051. DOI: 10.1093/nar/gkz757. View